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A novel and green nanoparticle 
formation approach to forming low-
crystallinity curcumin nanoparticles 
to improve curcumin’s 
bioaccessibility
Ali Ubeyitogullari & ozan n. ciftci*
Health-promoting effects of curcumin are well-known; however, curcumin has a very low bioavailability 
due to its crystalline structure. the main objective of this study was to develop a novel green 
nanoparticle formation method to generate low-crystallinity curcumin nanoparticles to enhance the 
bioavailability of curcumin. Nanoporous starch aerogels (NSAs) (surface area of 60 m2/g, pore size 
of 20 nm, density of 0.11 g/cm3, and porosity of 93%) were employed as a mold to produce curcumin 
nanoparticles with the help of supercritical carbon dioxide (Sc-co2). the average particle size of the 
curcumin nanoparticles was 66 nm. Impregnation into NSAs decreased the crystallinity of curcumin and 
did not create any chemical bonding between curcumin nanoparticles and the nSA matrix. the highest 
impregnation capacity was 224.2 mg curcumin/g NSA. Curcumin nanoparticles significantly enhanced 
the bioaccessibility of curcumin by 173-fold when compared to the original curcumin. The concentration 
of curcumin in the bioaccessible fraction was improved from 0.003 to 0.125 mg/mL by impregnation of 
curcumin into NSAs (42-fold). This is a novel approach to produce food grade curcumin nanoparticles 
with reduced crystallinity and maximize the utilization of curcumin due to increased bioaccessibility.
Curcumin (diferuloylmethane) is a polyphenolic compound which is mainly extracted from turmeric rhizome 
(Curcuma longa)1. It has been used in Ayurvedic medicine as a traditional pharmaceutical agent for thousands of 
years2. The health benefits of curcumin are well-documented; specifically, curcumin exhibits anticancer, antiviral, 
antioxidant, anti-inflammatory, antimicrobial, hypoglycemic, and antirheumatic properties2,3. Moreover, thera-
peutic applications of curcumin in the treatment of cancer, diabetes, cardiovascular diseases, neurodegenerative 
diseases, and gastrointestinal irritation are well established2–4. Human clinical trials have shown that curcumin is 
safe at high doses (12 g/day)5.
Although the health benefits of curcumin are well recognized, curcumin’s full potential has not yet been real-
ized due to its low bioavailability. The bioavailability of curcumin is very low (~1%)6 due to its low water solubility, 
chemical instability and crystalline structure. Furthermore, incorporation of curcumin into foods is a major 
challenge from a technological and food quality standpoint because crude curcumin is a crystalline powder that 
is insoluble in water and poorly soluble in fats and oils, which affects the sensory and quality of the food product 
negatively.
Decreasing size of the bioactives is known to improve their solubilization and thereby their bioavailability; 
therefore, in recent years, there has been many research efforts to decrease the size of curcumin to increase its bio-
availability7,8. Different approaches, such as formation of emulsions9–15, cyclodextrin complexes16,17, nanosuspen-
sions by antisolvent precipitation18, and polysaccharide complexes19–21, and synthesis of colloidal particles1 have 
been used to improve the bioavailability of curcumin. However, the use of organic toxic solvents (i.e. chloroform) 
and surfactants limit their applications in food products; furthermore, most of those techniques produce liquid 
products which are difficult to handle and store. In addition, curcumin has low stability in aqueous medium18 
which could be another disadvantage of some of those liquid formulations.
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After exploring the new opportunities offered by supercritical fluid technology, and especially the green pro-
cessing by SC-CO2 technology, there has been several efforts to decrease the size of curcumin using SC-CO2. 
So far, solid lipid particles by Particles Generated from Gas Saturated Solution (PGSS)22, micronization by 
Atomized Rapid Injection Solvent Extraction (ARISE)23,24, loading nanofibrous silk fibroin by Solution-Enhanced 
Dispersion via SC-CO2 (SEDS)25, and Precipitation by Pressure Reduction of Gas-Expanded Liquids (PPRGEL)26 
have been employed to decrease the size of curcumin using SC-CO2. However, the difficulty in controlling the 
particle size, the use of organic solvents like acetone, and limited number of food-grade chemicals used dur-
ing the production are still significant drawbacks of the current techniques. Therefore, there is a critical need 
for a new green approach to decrease the size and crystallinity of curcumin and in turn to improve curcumin’s 
bioavailability.
In our previous studies, low-crystallinity phytosterol nanoparticles were produced by impregnating a 
phytosterol-SC-CO2 solvato complex in the nanoporous starch aerogel (NSA) in a two-step process where first 
NSA was formed and then phytosterols were impregnated into the NSA using SC-CO2 27,28. The size of the phy-
tosterol particles formed in those studies ranged between 59 and 87 nm and the solubility of the phytosterols in 
water and gastrointestinal fluids was significantly improved. In this study, a novel single-step simultaneous NSA 
formation-nanoparticle formation method is introduced to form low-crystallinity curcumin nanoparticles.
Aerogels have been receiving a growing interest due to their outstanding properties (high surface area, nano-
porous structure, and very low density) in biomedical and pharmaceutical industries. However, their food appli-
cations have not been explored yet. Starch is a great candidate to produce food-grade aerogels with nanoporous 
structure due to its gelatinization without any chemical cross-linker. Moreover, starch is a biodegradable, biocom-
patible, abundant, inexpensive and bio-based source for aerogel production29.
The main objective of this study was to develop a novel green nanoparticle formation approach to forming 
low-crystallinity curcumin nanoparticles that has improved bioaccessibility. The specific objectives were to: (a) 
develop a single-step simultaneous NSA formation-low-crystallinity curcumin nanoparticle formation process, 
(b) characterize curcumin nanoparticles impregnated in the NSAs, and (c) determine the bioaccessibility of the 
low-crystallinity curcumin nanoparticles using simulated digestion.
Results and Discussion
This study introduces a novel green nanomanufacturing approach to generating low-crystallinity curcumin nan-
oparticles utilizing nanoporous starch aerogels in conjunction with SC-CO2 technology. The NSA formation pro-
cess that was reported previously consisted of three major steps: gelatinization of wheat starch to form a hydrogel, 
replacing the water in the hydrogel with ethanol to produce an alcogel, and finally SC-CO2 drying of the alcogel 
to form an aerogel29. Gelatinization of starch results in swelling of the granules, amylose leaching and disruption 
of the ordered structure. On cooling, swollen granule sacs produce porous gel30. Solvent exchange was carried 
out prior to SC-CO2 drying because ethanol has higher solubility than water in SC-CO2 31. Drying of the alcogel 
is critical to preserve the porous structure of the gel. Our previous studies have shown that air drying results in 
shrinkage of the structure and loss of all the pores due to high surface tension and capillary forces during drying29. 
However, SC-CO2 drying prevents the formation of liquid-vapor meniscus by eliminating the capillary forces in 
the pore walls (surface tension of the liquid in the pores)32. Therefore, SC-CO2 drying preserved the nanoporous 
structure of the alcogels and generated NSAs with outstanding properties: surface area of 60.4 ± 3.0 m2/g, pore 
size of 19.9 ± 2.5 nm, pore volume of 0.26 ± 0.01 cm3/g, density of 0.11 ± 0.00 g/cm3, and porosity of 92.8 ± 0.2%.
In this study, a simultaneous NSA formation-low-crystallinity curcumin nanoparticle formation process was 
developed (Fig. 1). NSAs were employed as a mold to produce curcumin nanoparticles in the nanopores of the 
aerogels. Ethanol-curcumin solvato complex diffused into the pores of NSAs during the last step of the solvent 
exchange. Then, the ethanol in the alcogel matrix was removed by SC-CO2 drying. During drying, curcumin was 
recrystallized from ethanol-curcumin solvato complex by anti-solvent action of the SC-CO2 in the pores of the 
NSAs which acted as a template and prevented the formation of long and well-ordered curcumin crystals (Fig. 1). 
As more ethanol was dissolved in the SC-CO2, curcumin started to precipitate from the ethanol-curcumin solvato 
complex in the pores of the NSA. The ethanol-curcumin solvato complex was confined in nanopores; meaning, 
there were limited amount of curcumin molecules in a small area; therefore, nanoparticles were formed. At the 
same time, a quick precipitation occurred in the nanopores, as a result, formation of well-ordered curcumin crys-
tals was prevented. At 10 MPa and 40 °C, solubility of curcumin in SC-CO2 is very low (~4 * 10−7 g/L)33; therefore, 
while ethanol is dissolved in the SC-CO2 and carried outside, curcumin stays in the NSA. This novel nanomanu-
facturing method eliminated the additional SC-CO2 impregnation step after SC-CO2 drying which was the case 
in our previous phytosterol nanoparticle formation study27.
Few studies have reported formation of curcumin particles using SC-CO2 technology by PGSS, PPRGEL, 
ARISE, and SEDS processes22–26. PGSS technique uses CO2 as a solute. In PGSS process, SC-CO2 is dissolved in 
tristearin/soy phosphatidylcholine/DMSO/curcumin mixture and curcumin loaded solid lipid particles are pro-
duced by micronization of that mixture22. PPRGEL, a similar method to PGSS, is employed to produce curcumin 
particles by atomization of curcumin/acetone solution into water26. In addition, ARISE is based on atomization 
of curcumin mixture into a vessel pressurized with CO2. Feed solution is composed of curcumin/polyvinylpyrro-
lidone (PVP), hydroxypropyl-β-cyclodextrin (HPβCD), or both in organic solvents like methanol, ethanol or 
acetone23. Furthermore, SEDS process is based on precipitation of curcumin from acetone solution in SC-CO2. 
Curcumin-silk fibroin nanofibrous matrix is also produced using SEDS process25. However, the above-mentioned 
techniques do not provide a full control over the particle formation and result in particle agglomeration. None 
of those techniques reported any change in the crystallinity of the particles. In addition, the use of toxic solvents 
such as acetone and methanol makes those techniques not applicable in food industry. In this study, formation of 
low-crystallinity curcumin nanoparticles was reported for the first time.
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Morphology. Figure 2 depicts the pictures of the empty NSA (Fig. 2a), curcumin impregnated NSA at 60 °C 
(CUR-NSA-60 °C; Fig. 2b) and curcumin impregnated NSA at room temperature (CUR-NSA-RT; Fig. 2c). 
Both CUR-NSA-60 °C and CUR-NSA-RT had a uniform orange color in the matrix of aerogel monolith which 
indicates a successful diffusion of curcumin into the center of the monolith during solvent exchange. However, 
CUR-NSA-60 °C had darker orange color compared to CUR-NSA-RT due to higher impregnation capacity 
(explained in the impregnation capacity section).
SEM images of the empty NSA, CUR-NSA-60 °C and CUR-NSA-RT are presented in Fig. 3. Empty NSA had 
three-dimensional open porous structure. This network structure was not affected by curcumin impregnation. 
Curcumin plate-like crystals with lengths ranging between 5 and 50 µm formed a coat on the surface of the 
CUR-NSA-60 °C (Fig. 3). Although similar curcumin crystals were observed on the surface of the CUR-NSA-RT, 
they were fewer compared to that of the surface of the CUR-NSA-60 °C because curcumin was recrystallized on 
the surface of the NSAs from the bulk excess ethanolic curcumin solution and formed long curcumin crystals 
due to the absence of the NSA matrix. At the center of the CUR-NSA-60 °C monoliths, some curcumin crystals 
were still observed due to the high concentration of curcumin in the ethanolic curcumin solution. However, the 
formation of those long crystals in the center of the CUR-NSA-RT monoliths was prevented with lower concen-
tration of ethanolic curcumin solution and the NSA matrix. Curcumin nanoparticles were observed in the center 
of both CUR-NSA-60 °C and CUR-NSA-RT monoliths at high magnification (Fig. 3). Curcumin nanoparticles 
impregnated in the NSA had a spherical morphology and their average particle size was 71 ± 8 and 66 ± 9 nm in 
the CUR-NSA-60 °C and CUR-NSA-RT, respectively. During SC-CO2 drying, curcumin nanoparticles showed 
a tendency to form agglomerates due to hydrophobic effect. Recently, Prasad et al. reported curcumin particle 
Figure 1. Illustration of the simultaneous NSA and low-crystallinity curcumin nanoparticle formation.
Figure 2. Pictures of (a) empty NSA and (b) CUR-NSA-60 °C and (c) CUR-NSA-RT.
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formation by PPRGEL process26. The mean particle size of curcumin varied between 0.4 µm and 30.8 µm and the 
particles had a plate-like structure. Besides, PGSS technique formed curcumin loaded solid lipid particle agglom-
erates with sizes over 100 µm22. Similarly, elongated thin curcumin crystals (~30 µm from ethanol and ~160 µm 
from acetone feed solutions) were fabricated with ARISE process24. On the other hand, SEDS process generated 
irregular-shaped agglomerated curcumin particles with the smallest average particle size of 325 nm34. However, 
those SC-CO2-based techniques did not provide a good control over the particle size and morphology. In this 
study, the formation of elongated curcumin crystals was prevented by the nanopores of the NSA.
crystallinity. XRD patterns of the crude CUR (Fig. 4a), physical mixture of crude CUR with empty NSA 
(224.2 mg crude CUR/g empty NSA) (Fig. 4b), CUR-NSA-60 °C (Fig. 4c), physical mixture of crude CUR with 
empty NSA (14.4 mg crude CUR/g empty NSA) (Fig. 4d), CUR-NSA-RT (Fig. 4e), and empty NSA (Fig. 4f) are 
presented in Fig. 4. The mass ratios of crude CUR/empty NSA were determined according to the impregnation 
capacity of CUR-NSA-RT (see the impregnation capacity section). Crude curcumin had several strong charac-
teristic peaks at 2θ = 8.8°, 12.1°, 14.3°, 17.2°, 18.0°, 21.1°, 23.1°, 24.4°, 25.5°, 27.2°, and 28.8°. Similar diffraction 
peaks were observed in the literature for crude curcumin powder23,25. These sharp peaks indicate the crystalline 
structure of crude curcumin. Empty NSAs had one broad peak, which means that empty NSAs were mainly in 
amorphous form due to disrupting the semi-crystalline structure of starch during gelatinization30. The XRD pat-
tern of the physical mixture of the crude curcumin with the empty NSA had the same characteristic diffraction 
Figure 3. SEM micrographs of empty NSA, CUR-NSA-60 °C and CUR-NSA-RT.
Figure 4. XRD patterns of (a) crude CUR, (b) physical mixture of crude CUR with empty NSA (224.2 mg crude 
CUR/g empty NSA), (c) CUR-NSA-60 °C, (d) physical mixture of crude CUR with empty NSA (14.4 mg crude 
CUR/g empty NSA), (e) CUR-NSA-RT, and (f) empty NSAs.
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peaks with the crude curcumin (Fig. 4a,b,d). However, the intensity of these peaks was much lower when cur-
cumin was impregnated into NSA at the same mass ratio (Fig. 4c,e), which shows the reduced crystallinity of the 
curcumin particles impregnated in the NSA. Curcumin in the CUR-NSA-60 °C had relatively higher crystallinity 
than that in CUR-NSA-RT due to higher amount of curcumin crystals on the surface (Figs. 3 and 4c,e). Reduced 
crystallinity enhances the dissolution rate of the water-insoluble bioactives due to the increase in the lattice free 
energy35,36; therefore, it is expected that the bioavailability of the low-crystallinity bioactives will be higher com-
pared to higher-crystallinity bioactives.
chemical interaction between the curcumin and the nSA. Figure 5 shows the absence of possi-
ble chemical interactions between the low-crystallinity curcumin nanoparticles and the NSA. The FTIR results 
revealed that there was no shifting on the location of the characteristic peaks of crude curcumin, meaning there 
was no interaction between the curcumin particles and the NSA (Fig. 5a,b,d). Empty NSA (Fig. 5c) showed char-
acteristic band between 3660 and 2990 cm−1 for the O–H stretching; and exhibited peaks at 2900 cm−1 for C–H 
stretching vibrations, 1150 cm−1 for C–O–C glucosidic bridge, and 1180 and 1020 cm−1 corresponding to C–C 
and C–O stretching vibrations which are consistent with the previous reports27,37. The FTIR spectrum of crude 
curcumin (Fig. 5d) exhibited a broad peak between 3450 and 3090 cm−1 and a sharp peak at 3510 cm−1 for O–H 
stretching; and peaks at 1625 cm−1 for mixed C=O and C=C vibrations, 1602 cm−1 for aromatic ring stretching 
vibrations, 1504 cm−1 for C–O and C–C vibrations, 1427 cm−1 for olefinic C-H bending vibrations, 1272 cm−1 for 
aromatic C–O stretching vibrations, and 1025 cm−1 for C–O–C stretching vibrations19,38. Even though impreg-
nated curcumin nanoparticles tended to recrystallize close to each other (Fig. 3), having no interaction between 
the impregnated curcumin and NSA indicates easy release of curcumin into water or gastrointestinal tract after 
oral administration.
impregnation capacity. Impregnation capacity of the CUR-NSA-RT, where impregnation was performed 
at room temperature (21 °C), was 14.4 mg CUR/g NSA (Fig. 6). When temperature of the impregnation increased 
to 60 °C (CUR-NSA-60 °C), the impregnation capacity significantly increased to 224.2 mg CUR/g NSA (Fig. 6) 
(p < 0.05). Impregnation capacity was basically based on the solubility of curcumin in ethanol. As the temper-
ature of ethanol was raised from 21 to 60 °C, the solubility of curcumin in ethanol increased from 4.4 ± 0.2 to 
17.2 ± 0.3 mg curcumin/mL ethanol. The increase in the solubility was not exactly at the same order with the 
Figure 5. ATR-FTIR spectra of the (a) CUR-NSA-RT, (b) CUR-NSA-60 °C, (c) empty NSA, and (d) crude 
CUR.
Figure 6. Curcumin impregnation capacities of the NSA generated at different impregnation temperatures.
6Scientific RepoRtS |         (2019) 9:19112  | https://doi.org/10.1038/s41598-019-55619-4
www.nature.com/scientificreportswww.nature.com/scientificreports/
increase in the impregnation capacity; a 3.9-fold increase in the solubility of curcumin in ethanol resulted in 
15.6-fold increase in the impregnation capacity. The reason for a drastic increase in the impregnation capacity at 
60 °C was the crystallization of curcumin in the saturated ethanolic curcumin solution on the surface of the NSA 
(Fig. 3) due to temperature drop to 40 °C during SC-CO2 drying.
Zou et al. investigated the use of excipient emulsions to improve the solubility and bioaccessibility of cur-
cumin11. Emulsions were formed by mixing an aqueous phase of 1% (w/w) Tween 80 buffer solution with corn oil. 
The emulsions were passed through a microfluidizer to prepare small particle size emulsions. Then, curcumin was 
added into the emulsions at a ratio of 0.3 mg curcumin/mL emulsion which is much lower than the impregnation 
capacity obtained in this study. The maximum amount of curcumin incorporated into the emulsions was limited 
by the solubility of curcumin in corn oil (~3.2 mg/mL)39. One more drawback of the emulsion formulations is that 
the oil phase (where curcumin is dissolved) in the emulsions is in contact with an aqueous phase which increases 
the chemical degradation of curcumin because of low stability of curcumin in an aqueous medium18.
In another study, zein-curcumin colloidal particles were synthesized using an antisolvent precipitation 
method1. Solvents like methanol, ethanol and isopropyl alcohol were used with and without stabilizers (sodium 
caseinate or PVP K-30) to dissolve zein-curcumin mixture. Loading capacity of zein-curcumin colloidal parti-
cles was lower than that of CUR-NSA-60 °C and ranged between 1.6 and 4.1% (w/w) depending on the ratio of 
zein and curcumin used. In that study, 0.05% (w/w) Tween 80 was required to have a dispersion of the colloidal 
particles which limits the application of those particles in foods. Furthermore, soy soluble polysaccharides were 
used as nanocarrier for curcumin where curcumin was first dissolved in ethanol and then added to an aqueous 
mixture of a polysaccharide solution20. That study reported the highest loading capacity was 4.49 mg CUR/g pol-
ysaccharide, which is fifty times lower than the highest impregnation capacity (224.2 mg CUR/g NSA) obtained 
in this study.
Simulated digestion. Low-crystallinity curcumin nanoparticles, both CUR-NSA-RT and CUR-NSA-60 °C, 
had significantly higher in vitro bioaccessibility compared to crude CUR (Fig. 7). The bioaccessibility of crude 
curcumin was only 0.4%, which was expected due to its low water solubility and crystalline structure. The highest 
bioaccessibility of curcumin was obtained with impregnation at room temperature (CUR-NSA-RT) (p < 0.05). 
The bioaccessibility of the CUR-NSA-RT (69.1%) was 173-fold higher than that of crude curcumin (Fig. 7). 
Although the bioaccessibility of crude CUR-NSA physical mixture (0.4%) and CUR-NSA-60 °C (2.2%) were not 
significantly different (p > 0.05), CUR-NSA-60 °C resulted in a significantly higher concentration of curcumin in 
the bioaccessible fraction (0.052 mg/mL) than the crude curcumin (0.003 mg/mL). The highest curcumin concen-
tration in the bioaccessible fraction was achieved with CUR-NSA-RT as 0.125 mg/mL, which was 42 times higher 
than that of crude curcumin. Although the impregnation capacity of CUR-NSA-60 °C was significantly higher 
than that of CUR-NSA-RT (Fig. 6), both the bioaccessibility and curcumin concentration in the bioaccessible 
fraction of CUR-NSA-60 °C were significantly lower (p < 0.05). As discussed before, dissolving curcumin at 60 °C 
formed a higher concentration ethanolic curcumin solution compared to the one prepared at room temperature. 
When the hydrogel was immersed in the curcumin solution, there were more curcumin on the surface of the alco-
gel. When the alcogel was dried, the curcumin on the surface of the alcogel crystallized on the surface of the aero-
gel. Because of the high concentration of the solution prepared at 60 °C, there were significantly higher amount of 
well-ordered plate-like curcumin crystals on the aerogel (Fig. 3); therefore, a higher impregnation capacity was 
obtained. However, those well-ordered plate-like crystals were not bioaccessible after simulated digestion due to 
their large size and well-ordered structure, which led to a lower bioaccessibility and lower concentration in the 
bioaccessible fraction of CUR-NSA-60 °C.
Figure 8 depicts the pictures and TEM images of the bioaccessible fractions obtained after simulated digestion 
of the physical mixture of crude CUR with empty NSA and CUR-NSA-RT. The color of the bioaccessible frac-
tion of CUR-NSA-RT (Fig. 8b) was darker compared to crude curcumin (Fig. 8a), indicating a higher curcumin 
concentration. TEM images of the bioaccessible fractions revealed the particle size of the curcumin particles 
in the bioaccessible fractions. The size of the curcumin particles in the bioaccessible fraction of CUR-NSA-RT 
Figure 7. Bioaccessibility and concentration of curcumin in the samples after simulated digestion. Different 
lower-case letters show statistical significance in the bioaccessibility of curcumin (P < 0.05) and different capital 
letters show statistical significance in curcumin concentration in the bioaccessible fraction of the samples 
(P < 0.05).
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(10 ± 1 nm) was significantly smaller than that of crude curcumin (67 ± 9 nm) (p < 0.05). The smaller curcumin 
particles are expected to have higher absorption after digestion because of the higher permeability trough biolog-
ical barriers40,41. To illustrate, silver nanoparticles (10, 20, 75 and 110 nm) were investigated at the same concen-
tration for their epithelial permeability using T84 human colonic epithelial cells, and the particle size of 10 nm 
resulted in the highest permeability42. Therefore, it is expected that smaller curcumin particles in the bioaccessible 
fraction will lead to a higher bioavailability of curcumin due to higher absorption rates.
It is necessary to determine the stability and solubility of the curcumin particles in digestion fluids with chang-
ing environment like pH, and ionic strength in addition to physical characterization after particle formation. 
Simulated digestion is a useful tool to determine performance of the curcumin particles under gastrointestinal 
conditions in a short time43. Despite of the efforts to form curcumin particles using SC-CO2 technology (PGSS, 
ARISE, SEDS and PPRGEL), none of those studies determined the bioaccessibility of their products. Among the 
other methods, Aditya et al. investigated the oral bioavailability of β-lactoglobulin-curcumin nanosuspensions 
using Caco-2 cells18. The bioavailability of crude curcumin was ~2.7% after 3 h incubation and it was increased 
to ~3.1% with crystalline curcumin nanosuspensions without β-lactoglobulin. The highest bioavailability was 
achieved with β-lactoglobulin-curcumin nanosuspension as ~4%. However, those formulations are pH depend-
ent and may not be stable in certain type of foods and protein-curcumin nanosuspensions may agglomerate due 
to different pHs throughout gastrointestinal tract. The bioavailability of curcumin nanoparticles obtained in this 
study is expected to be higher than that of β-lactoglobulin-curcumin nanosuspensions because curcumin nano-
particles were smaller (66 nm versus 150–175 nm) and had less crystallinity. Nanoemulsions, zein nanosuspen-
sions and nanoliposomes were also explored to improve the bioaccessibility of curcumin12. Those formulations 
were prepared by injecting ethanol/oil solution into Tween 80 and phosphate buffer saline (PBS) buffer solution 
mixture. Loading capacities were 11.7, 3.1 and 0.4% (w/w) for protein, phospholipid and lipid nanoparticle sus-
pensions, respectively. Although loading capacities of protein and phospholipid nanoparticle suspensions were 
relatively high, but still lower than the impregnation capacity obtained in this study (18.3%, w/w), curcumin was 
not stable in those formulation; 59–79.2% of the curcumin degraded during simulated digestion. A high bioac-
cessibility (91.8%) was reported for lipid nanoparticle suspensions (nanoemulsions) but the concentration in the 
bioaccessible fraction was only 109 µg/mL12. The high bioaccessibility (91.8%) obtained with lipid nanoparticle 
suspension was a reason of low loading capacity (0.4%, w/w). In another study by the same research group, the 
bioaccessibility of curcumin was around 70% when excipient emulsions were used and the highest concentration 
of curcumin in the bioaccessible fraction was ~90 µg/mL11. Those emulsion studies do not have a comparison 
with the commercial curcumin, therefore the rate of improvement in the bioaccessibility of crude curcumin is 
not clear.
Li et al. developed curcumin loaded nanoemulsions that were covered by chitosan in order to protect cur-
cumin from degradation10. The prepared nanoemulsions had a curcumin concentration of 0.548 mg/mL. 
Although chitosan coating was effective in reducing the degradation of curcumin during thermal and UV irra-
diation treatments, the bioaccessibility of curcumin was slightly (less than 5% compared to nanoemulsions) 
decreased with middle and high molecular weight chitosan coating of the nanoemulsions.
In another approach, free lipid droplets, lipid-loaded alginate beads and lipid-loaded carrageenan beads were 
loaded with curcumin21. The size of the alginate beads ranged between 2 and 3 mm whereas carrageenan beads 
had a diameter in the range of 3–4 mm. Curcumin concentration in the bioaccessible fraction after simulated 
digestion was ~35, ~15 and ~8 µg/mL for free lipid droplets, loaded alginate beads and loaded carrageenan beads, 
respectively. The current study achieved at least 3.6-fold higher curcumin concentration in the bioaccessible frac-
tion. In another study, bioaccessibility of soy soluble polysaccharides and curcumin complexes was determined 
by a sequential in vitro gastric and intestinal digestion20; however, oral phase digestion was missing in that study44. 
They reported the bioaccessibility of crude curcumin as 24.8 and 34.8% at pH 7.0 and 4.0, respectively. The bioac-
cessibility of curcumin was improved up to 76.8 and 82.8% by soy soluble polysaccharide-curcumin complexes at 
pH 7.0 and 4.0, respectively, meaning a 3-fold increase in the bioaccessibility of curcumin.
Figure 8. TEM images and gross appearance (inset images) of the bioaccessible fractions of (a) physical 
mixture of crude CUR with empty NSA, and (b) CUR-NSA-RT.
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conclusions
This study has described a novel nanomanufacturing method utilizing SC-CO2 technology and NSAs to fabri-
cate low-crystallinity curcumin nanoparticles to improve the bioavailability of curcumin. Curcumin nanopar-
ticles were in spherical shape and their average size was 66 nm. The crystallinity of curcumin was decreased by 
impregnation into NSAs which enhances the dissolution rate of curcumin in the digestive fluids and consequently 
improves its bioavailability. There was no chemical bonding between impregnated curcumin nanoparticles and 
the NSA, therefore release mechanisms of curcumin nanoparticles is expected to improve. The highest impregna-
tion capacity was obtained at an impregnation temperature of 60 °C as 224.2 mg curcumin/g NSA. However, the 
bioaccessibility of curcumin was maximized with an impregnation at room temperature. The highest bioacces-
sibility and concentration of curcumin in the bioaccessible fraction were 69.1% and 0.125 mg/mL, respectively. 
Curcumin nanoparticles had 173-fold higher bioaccessibility than crude curcumin and the concentration of cur-
cumin in the bioaccessible fraction was significantly improved by impregnation into NSAs (42-fold).
This is a new green nanomanufacturing technology to form low-crystallinity bioactives. This novel approach 
has the potential to (i) enhance the efficacy of various bioactive compounds; (ii) allow food manufacturers to 
incorporate lipophilic bioactive compounds into foods to produce health and wellness improving foods in a 
green and simple way; (iii) increase the cost-benefit ratio of various bioactive compounds; (v) make the handling, 
storage & transportation of bioactives easy, because NSA formulation is a dry powder whereas most of the current 
lipophilic bioactive delivery systems are liquid.
Methods
Materials. Crude curcumin (>98% purity) was acquired from Acros Organics (NJ, USA). The composition 
of crude curcumin was determined in the lab by high-performance liquid chromatography (HPLC) and found to 
be 2.0 ± 0.3% bisdemethoxycurcumin, 15.0 ± 0.4% demethoxycurcumin, and 83.0 ± 0.7% curcumin. Liquid CO2 
(99.99% purity) was obtained from Matheson Tri-Gas, Inc. (NE, USA).
The α-Amylase enzyme (from Bacillus subtilis, 160,000 BAU/g) was purchased from MP Biomedicals (OH, 
USA). Pepsin (3,616 U/mg protein), pancreatin (neutral protease: 208 USP U/mg solid; α-Amylase: 223 U/mg 
solid; lipase: 38.5 USP U/mg solid), pancreatic lipase (419 U/mg protein) and bile extract were all of porcine ori-
gin and obtained from Sigma-Aldrich (MO, USA). Amano lipase A (from fungus Aspergillus niger, 132,000 U/g) 
was provided by Amano Enzyme Inc. (IL, USA).
formation of nanoporous starch aerogel (nSA). The NSA samples were produced from wheat starch 
according to the method of Ubeyitogullari and Ciftci using the optimized NSA formation conditions29. Briefly, 
wheat starch solution (10%, w/w) was gelatinized in a closed high-pressure reactor (4520 Bench Top Reactor, Parr 
Instrument Company, IL, USA) at 120 °C and 600 rpm for 20 min to obtain a hydrogel which was subsequently 
retrograded at 4 °C for 48 h. Then, the hydrogels were converted to alcogels with a five-step solvent exchange step 
by soaking the hydrogels in 30, 50, 70, and 100% (v/v) ethanol for 1 h, and in 100% ethanol for 24 h. Then the 
alcogels were converted to NSAs by removing the ethanol from the alcogels using SC-CO2 drying at 40 °C and 
10 MPa for 4 h at a CO2 flow rate of 0.5 L/min (measured at ambient conditions) which were selected based on 
our previous study where the drying temperature, pressure and flow rate of CO2 were optimized for the highest 
surface area29. SC-CO2 drying of the alcogels was carried out in a custom-made laboratory scale SC-CO2 drying 
system which employed double head high pressure syringe pump (Model 260D, Teledyne Isco Inc., NE, USA) for 
pressurization. Details and operation of the SC-CO2 drying system were given somewhere else28.
Simultaneous formation of low-crystallinity curcumin nanoparticles impregnated in the nSA. 
Formation of low-crystallinity curcumin nanoparticles impregnated into NSA was based on a modified NSA for-
mation method described above. Excess amount of curcumin (1 g) was mixed with ethanol (40 mL) at room tem-
perature (21 °C) and the undissolved curcumin was removed by filtration through a 0.45 µm pore-size filter. Then, 
the saturated curcumin solution was used in the last step of the solvent exchange described in the above section 
instead of 100% ethanol to obtain an alcogel called CUR-alcogel. Afterwards, CUR-alcogels were dried with 
SC-CO2 using the same system and conditions used in the formation of NSA to obtain curcumin impregnated 
NSA (CUR-NSA). In addition to ethanolic curcumin solution prepared at room temperature (21 °C), CUR-NSAs 
were prepared from ethanolic curcumin solution prepared at 60 °C using the same procedure. CUR impregnated 
NSAs were called CUR-NSA-60 °C or CUR-NSA-RT depending on the impregnation temperature of 60 °C or 
room temperature (RT), respectively. CUR-NSAs were stored in the freezer at −18 °C until analyzed.
Morphology. The morphology of the NSA and the CUR-NSA was analyzed by field emission scanning elec-
tron microscope (S4700 FE-SEM, Hitachi, Tokyo, Japan) under low vacuum mode at 5 kV and 15 mA. The spec-
imens were prepared by cutting thin cross-sections from the surface and the center of the NSA monoliths. The 
specimens were then sputter-coated with a chromium layer under vacuum (Desk V HP TSC, Denton Vacuum 
LLC, NJ, USA) prior to analysis.
The morphology of the curcumin in the bioaccessible fraction after simulated digestion (described in the 
simulated digestion section) was analyzed by transmission electron microscopy (H-7500 TEM, Hitachi, Tokyo, 
Japan) at an accelerating voltage of 80 kV. One drop of bioaccessible fraction was placed on 230 mm copper grids 
and air dried. Then, the samples were negatively stained with 1% phosphotungstic acid. After drying at room tem-
perature (21 °C) for 8 h, the samples were examined by TEM. Furthermore, particle size of the curcumin particles 
in the NSA and in the bioaccessible fraction after simulated digestion was measured from the SEM and TEM 
images by examining the size of the randomly selected 50 particles using ImageJ v. 1.50i software, respectively.
crystallinity. Crystallinity of the CUR-NSA-RT, physical mixture of crude CUR with empty NSA (14.4 mg 
crude CUR/g empty NSA), CUR-NSA-60 °C, physical mixture of crude CUR with empty NSA (224.2 mg crude 
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CUR/g empty NSA), empty NSA and crude CUR was studied with x-ray diffraction (XRD) analysis using a 
PANalytical Empyrean Diffractometer (Empyrean, PANalytical B.V., Almelo, Netherlands) equipped with a 
PIXcel3D detector. The instrument was operated with 1D detection at 45 kV and 40 mA. The powdered samples 
were scanned from 2° to 40° (2θ) with a sampling interval of 0.05°.
fourier-transform infrared spectroscopy. The chemical interaction between the curcumin and the NSA 
was studied by Attenuated Total Reflectance Fourier-Transform Infrared Spectrometer (ATR-FTIR) (Nicolet 380, 
Thermo Scientific, MA, USA). FTIR spectroscopy was performed between 4000 and 400 cm−1 at spectral resolu-
tion of 4 cm−1 with 128 scans.
Determination of the curcumin impregnation capacity. Curcumin was extracted from CUR-NSA 
(0.1 g) by acetonitrile at room temperature (21 °C) with occasional vortexing. Then, NSA was separated from the 
mixture by 0.45 µm pore-size filter. Finally, curcumin concentration in the filtrate was determined using HPLC as 
described in the curcumin analysis section. The impregnation capacity was reported as mg CUR/g NSA.
curcumin analysis. Curcumin was quantified by an HPLC (Agilent 1100 Series, Agilent Technologies, 
Germany) equipped with a variable wavelength detector (VWD) according to the method of Lungare et al.45 
Briefly, an aliquot (20 µL) was injected onto a reversed phase Gemini C18 110 A column (150 × 4.6 mm, 5 µm; 
Phenomenex, CA, USA) that was maintained at 30 °C. The mobile phase consisted of acetonitrile and 5% acetic 
acid at a ratio of 45:55 (v/v) at a flow rate of 0.8 mL/min. The elution was monitored at 420 nm. Curcumin was 
quantified using an external calibration curve that was prepared using curcumin solutions at varying concentra-
tions (0.1–50 µg/mL in acetonitrile).
Simulated digestion. A simulated gastrointestinal digestion method was adopted from Minekus et al. to 
determine in vitro bioaccessibility of the curcumin46. Simulated salivary fluid (SSF), simulated gastric fluid (SGF) 
and simulated intestinal fluid (SIF) were prepared using a method reported previously46. Curcumin particles 
impregnated in the NSA and the physical mixture of crude curcumin with empty NSA (14.4 mg crude CUR/g 
empty NSA) was used as a control. All digestion experiments were carried out in triplicate.
Oral phase. First, the curcumin impregnated NSA sample (0.25 g) and SSF electrolyte stock solution (3.5 mL) 
were added into a flask. Then, α-amylase solution (0.5 mL, 750 U/mL) was included. Subsequently, 0.3 M CaCl2 
(25 µL) and deionized water (0.975 mL) were added. Finally, pH of the mixture was adjusted to pH 7.0 and the 
mixture was agitated in a shaking water bath for 30 sec at 37 °C and 150 rpm46,47.
Gastric phase. After the oral digestion, oral bolus (5 mL) was mixed with SGF electrolyte stock solution 
(3.25 mL, pH 3.0) and the pH was adjusted to 3.0 using 1 M HCl (75 µL). Afterwards, porcine pepsin solution 
(0.5 mL, 40 000 U/mL) and fungal lipase (0.25 mL, 1000 U/mL) were added. There is no commercial gastric lipase 
and therefore fungal lipase was included as an analogue to human gastric lipase48. Then, 0.3 M CaCl2 (2.5 µL) and 
deionized water (0.923 mL) were included. The final mixture was incubated at 37 °C and 100 rpm for 2 h.
Intestinal phase. After the gastric digestion, SIF electrolyte stock solution (6.125 mL, pH 7.0) was mixed with 
the gastric chyme (10 mL). Then, pancreatin solution (1.25 mL) was prepared in SIF electrolyte stock solution 
according to α-amylase activity and added into the mixture. Moreover, extra porcine pancreatic lipase was added 
to achieve a lipase activity of 2000 U/mL. Then, fresh bile solution (0.625 mL, 320 mM, prepared in SIF), 0.3 M 
CaCl2 (20 µL) and deionized water (1.95 mL) were added to the mixture and the pH was adjusted to pH 7.0 using 
1 M HCl (30 µL). Lastly, the final mixture was incubated at 37 °C and 100 rpm for 2 h.
Bioaccessible fraction. The bioaccessible fraction after digestion was separated using the method of Alemany et al.49  
Immediately after simulated digestion experiments, the flasks were placed into an ice bath to stop digestion. 
Then, bioaccessible fraction of the digested samples was attained by centrifugation at 4 °C at 4000 rpm for 90 min 
(Allegra X-15R, Beckman Coulter, CA, USA). The bioaccessibility (%) of curcumin was calculated as follows:
= ×Bioaccessibility Curcumin in the bioaccessible fraction
Total curcumin included
(%) 100 (1)
The concentration of curcumin in the bioaccessible fraction was determined using the HPLC method 
described above. The samples were filtered through 0.45 µm pore-size filter prior to analysis.
Statistical analysis. Statistical analysis of the obtained data was performed using Minitab® 16.1.1 software 
(Minitab Inc., State College, PA, USA). Tukey’s multiple comparison test was applied and the differences among 
treatments were considered to be statistically significant when p < 0.05.
Received: 26 April 2019; Accepted: 18 November 2019;
Published: xx xx xxxx
References
 1. Patel, A., Hu, Y., Tiwari, J. K. & Velikov, K. P. Synthesis and characterisation of zein-curcumin colloidal particles. Soft Matter 6, 
6192–6199, https://doi.org/10.1039/C0SM00800A (2010).
 2. Shen, L., Liu, C.-C., An, C.-Y. & Ji, H.-F. How does curcumin work with poor bioavailability? Clues from experimental and 
theoretical studies. Sci. Rep. 6, 20872, https://doi.org/10.1038/srep20872 (2016).
1 0Scientific RepoRtS |         (2019) 9:19112  | https://doi.org/10.1038/s41598-019-55619-4
www.nature.com/scientificreportswww.nature.com/scientificreports/
 3. Anand, P., Kunnumakkara, A. B., Newman, R. A. & Aggarwal, B. B. Bioavailability of curcumin: Problems and promises. Mol. 
Pharm. 4, 807–818, https://doi.org/10.1021/mp700113r (2007).
 4. Jeffrey, M. W. & Xia, L. Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: Some uses and the 
establishment and biological basis of medical efficacy. CNS & Neurological Disorders - Drug Targets 12, 487–497, https://doi.
org/10.2174/1871527311312040007 (2013).
 5. Lao, C. D. et al. Dose escalation of a curcuminoid formulation. BMC Complement. Altern. Med. 6, 10, https://doi.org/10.1186/1472-
6882-6-10 (2006).
 6. Siviero, A. et al. Curcumin, a golden spice with a low bioavailability. Journal of Herbal Medicine 5, 57–70, https://doi.org/10.1016/j.
hermed.2015.03.001 (2015).
 7. Acosta, E. Bioavailability of nanoparticles in nutrient and nutraceutical delivery. Curr. Opin. Colloid Interface Sci. 14, 3–15, https://
doi.org/10.1016/j.cocis.2008.01.002 (2009).
 8. Kesisoglou, F., Panmai, S. & Wu, Y. Nanosizing — Oral formulation development and biopharmaceutical evaluation. Adv. Drug Del. 
Rev. 59, 631–644, https://doi.org/10.1016/j.addr.2007.05.003 (2007).
 9. Marefati, A., Bertrand, M., Sjöö, M., Dejmek, P. & Rayner, M. Storage and digestion stability of encapsulated curcumin in emulsions 
based on starch granule Pickering stabilization. Food Hydrocolloids 63, 309–320, https://doi.org/10.1016/j.foodhyd.2016.08.043 
(2017).
 10. Li, J., Hwang, I.-C., Chen, X. & Park, H. J. Effects of chitosan coating on curcumin loaded nano-emulsion: Study on stability and in 
vitro digestibility. Food Hydrocolloids 60, 138–147, https://doi.org/10.1016/j.foodhyd.2016.03.016 (2016).
 11. Zou, L. et al. Enhancing nutraceutical bioavailability using excipient emulsions: Influence of lipid droplet size on solubility and 
bioaccessibility of powdered curcumin. Journal of Functional Foods 15, 72–83, https://doi.org/10.1016/j.jff.2015.02.044 (2015).
 12. Zou, L. et al. Food-grade nanoparticles for encapsulation, protection and delivery of curcumin: comparison of lipid, protein, and 
phospholipid nanoparticles under simulated gastrointestinal conditions. RSC Adv. 6, 3126–3136, https://doi.org/10.1039/
C5RA22834D (2016).
 13. Lu, X., Li, C. & Huang, Q. Combining in vitro digestion model with cell culture model: Assessment of encapsulation and delivery of 
curcumin in milled starch particle stabilized Pickering emulsions. Int. J. Biol. Macromol 139, 917–924, https://doi.org/10.1016/j.
ijbiomac.2019.08.078 (2019).
 14. Araiza Calahorra, A. & Sarkar, A. Pickering emulsion stabilized by protein nanogel particles for delivery of curcumin: Effects of pH 
and ionic strength on curcumin retention. Food Structure 21, Art no. 100113, https://doi.org/10.1016/j.foostr.2019.100113 (2019).
 15. Araiza-Calahorra, A., Akhtar, M. & Sarkar, A. Recent advances in emulsion-based delivery approaches for curcumin: From 
encapsulation to bioaccessibility Trends in Food Science and Technology 71, 155–169, https://doi.org/10.1016/j.tifs.2017.11.009 
(2018).
 16. Shityakov, S. et al. Solubility profiles, hydration and desolvation of curcumin complexed with γ-cyclodextrin and hydroxypropyl-
γ-cyclodextrin. J. Mol. Struct. 1134, 91–98, https://doi.org/10.1016/j.molstruc.2016.12.028 (2017).
 17. Aytac, Z. & Uyar, T. Core-shell nanofibers of curcumin/cyclodextrin inclusion complex and polylactic acid: Enhanced water 
solubility and slow release of curcumin. Int. J. Pharm. 518, 177–184, https://doi.org/10.1016/j.ijpharm.2016.12.061 (2017).
 18. Aditya, N. P., Yang, H., Kim, S. & Ko, S. Fabrication of amorphous curcumin nanosuspensions using β-lactoglobulin to enhance 
solubility, stability, and bioavailability. Colloids Surf. B. Biointerfaces 127, 114–121, https://doi.org/10.1016/j.colsurfb.2015.01.027 
(2015).
 19. Li, J., Shin, G. H., Lee, I. W., Chen, X. & Park, H. J. Soluble starch formulated nanocomposite increases water solubility and stability 
of curcumin. Food Hydrocolloids 56, 41–49, https://doi.org/10.1016/j.foodhyd.2015.11.024 (2016).
 20. Chen, F.-P., Ou, S.-Y., Chen, Z. & Tang, C.-H. Soy soluble polysaccharide as a nanocarrier for curcumin. J. Agric. Food. Chem. 65, 
1707–1714, https://doi.org/10.1021/acs.jafc.6b05087 (2017).
 21. Zhang, Z. et al. Encapsulation of curcumin in polysaccharide-based hydrogel beads: Impact of bead type on lipid digestion and 
curcumin bioaccessibility. Food Hydrocolloids 58, 160–170, https://doi.org/10.1016/j.foodhyd.2016.02.036 (2016).
 22. Pedro, A. S. et al. Curcumin-loaded solid lipid particles by PGSS technology. J. Supercrit. Fluids 107, 534–541, https://doi.
org/10.1016/j.supflu.2015.07.010 (2016).
 23. Kurniawansyah, F., Mammucari, R. & Foster, N. R. Inhalable curcumin formulations by supercritical technology. Powder Technol. 
284, 289–298, https://doi.org/10.1016/j.powtec.2015.04.083 (2015).
 24. Kurniawansyah, F., Mammucari, R. & Foster, N. R. Polymorphism of curcumin from dense gas antisolvent precipitation. Powder 
Technol. 305, 748–756, https://doi.org/10.1016/j.powtec.2016.10.067 (2017).
 25. Xie, M. et al. Development of silk fibroin-derived nanofibrous drug delivery system in supercritical CO2. Mater. Lett. 167, 175–178, 
https://doi.org/10.1016/j.matlet.2015.12.151 (2016).
 26. Prasad, R., Patsariya, R. & Dalvi, S. V. Precipitation of curcumin by pressure reduction of CO2-expanded acetone. Powder Technol. 
310, 143–153, https://doi.org/10.1016/j.powtec.2016.12.042 (2017).
 27. Ubeyitogullari, A. & Ciftci, O. N. Phytosterol nanoparticles with reduced crystallinity generated using nanoporous starch aerogels. 
RSC Adv. 6, 108319–108327, https://doi.org/10.1039/C6RA20675A (2016).
 28. Ubeyitogullari, A. & Ciftci, O. N. Generating phytosterol nanoparticles in nanoporous bioaerogels via supercritical carbon dioxide 
impregnation: Effect of impregnation conditions. J. Food Eng. 207, 99–107, https://doi.org/10.1016/j.jfoodeng.2017.03.022 (2017).
 29. Ubeyitogullari, A. & Ciftci, O. N. Formation of nanoporous aerogels from wheat starch. Carbohydr. Polym. 147, 125–132, https://doi.
org/10.1016/j.carbpol.2016.03.086 (2016).
 30. Ratnayake, W. S. & Jackson, D. S. In Adv. Food Nutr. Res. Vol. Volume 55 221–268 (Academic Press, 2008).
 31. García-González, C. A., Alnaief, M. & Smirnova, I. Polysaccharide-based aerogels—Promising biodegradable carriers for drug 
delivery systems. Carbohydr. Polym. 86, 1425–1438, https://doi.org/10.1016/j.carbpol.2011.06.066 (2011).
 32. Pierre, A. C. & Pajonk, G. M. Chemistry of aerogels and their applications. Chem. Rev. 102, 4243–4266, https://doi.org/10.1021/
cr0101306 (2002).
 33. Zhan, S., Li, S., Zhao, Q., Wang, W. & Wang, J. Measurement and correlation of curcumin solubility in supercritical carbon dioxide. 
J. Chem. Eng. Data 62, 1257–1263, https://doi.org/10.1021/acs.jced.6b00798 (2017).
 34. Zhao, Z. et al. Formation of curcumin nanoparticles via solution-enhanced dispersion by supercritical CO(2). International Journal 
of Nanomedicine 10, 3171–3181, https://doi.org/10.2147/IJN.S80434 (2015).
 35. Babu, N. J. & Nangia, A. Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Cryst. Growth Des. 11, 2662–2679, 
https://doi.org/10.1021/cg200492w (2011).
 36. Brittain, H. G., Grant, D. J. R. & Myrdal, P. B. In Polymorphism in Pharmaceutical Solids Drugs and the Pharmaceutical Sciences (ed. 
Harry G. Brittain) 436–480 (CRC Press, 2009).
 37. Kenar, J. A., Eller, F. J., Felker, F. C., Jackson, M. A. & Fanta, G. F. Starch aerogel beads obtained from inclusion complexes prepared 
from high amylose starch and sodium palmitate. Green Chem. 16, 1921–1930, https://doi.org/10.1039/c3gc41895b (2014).
 38. Mohan, P. R. K., Sreelakshmi, G., Muraleedharan, C. V. & Joseph, R. Water soluble complexes of curcumin with cyclodextrins: 
Characterization by FT-Raman spectroscopy. Vib. Spectrosc 62, 77–84, https://doi.org/10.1016/j.vibspec.2012.05.002 (2012).
 39. Ahmed, K., Li, Y., McClements, D. J. & Xiao, H. Nanoemulsion- and emulsion-based delivery systems for curcumin: Encapsulation 
and release properties. Food Chem. 132, 799–807, https://doi.org/10.1016/j.foodchem.2011.11.039 (2012).
 40. Rein, M. J. et al. Bioavailability of bioactive food compounds: a challenging journey to bioefficacy. Br. J. Clin. Pharmacol. 75, 
588–602, https://doi.org/10.1111/j.1365-2125.2012.04425.x (2013).
1 1Scientific RepoRtS |         (2019) 9:19112  | https://doi.org/10.1038/s41598-019-55619-4
www.nature.com/scientificreportswww.nature.com/scientificreports/
 41. Sigfridsson, K., Lundqvist, A. J. & Strimfors, M. Particle size reduction for improvement of oral absorption of the poorly soluble drug 
UG558 in rats during early development. Drug Dev. Ind. Pharm. 35, 1479–1486, https://doi.org/10.3109/03639040903025855 
(2009).
 42. Williams, K. M., Gokulan, K., Cerniglia, C. E. & Khare, S. Size and dose dependent effects of silver nanoparticle exposure on 
intestinal permeability in an in vitro model of the human gut epithelium. Journal of Nanobiotechnology 14, 62, https://doi.
org/10.1186/s12951-016-0214-9 (2016).
 43. Hur, S. J., Lim, B. O., Decker, E. A. & McClements, D. J. In vitro human digestion models for food applications. Food Chem. 125, 
1–12, https://doi.org/10.1016/j.foodchem.2010.08.036 (2011).
 44. Mun, S., Kim, Y.-R. & McClements, D. J. Control of β-carotene bioaccessibility using starch-based filled hydrogels. Food Chem. 173, 
454–461, https://doi.org/10.1016/j.foodchem.2014.10.053 (2015).
 45. Lungare, S., Hallam, K. & Badhan, R. K. S. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug 
delivery. Int. J. Pharm. 513, 280–293, https://doi.org/10.1016/j.ijpharm.2016.09.042 (2016).
 46. Minekus, M. et al. A standardised static in vitro digestion method suitable for food - an international consensus. Food & Function 5, 
1113–1124, https://doi.org/10.1039/C3FO60702J (2014).
 47. Ubeyitogullari, A., Moreau, R., Rose, D. J., Zhang, J. & Ciftci, O. N. Enhancing the bioaccessibility of phytosterols using nanoporous 
corn and wheat starch bioaerogels. Eur. J. Lipid Sci. Technol., 1700229-n/a, https://doi.org/10.1002/ejlt.201700229 (2018).
 48. Lecomte, M. et al. Milk polar lipids affect in vitro digestive lipolysis and postprandial lipid metabolism in mice. J. Nutr. 145, 
1770–1777, https://doi.org/10.3945/jn.115.212068 (2015).
 49. Alemany, L. et al. Effect of simulated gastrointestinal digestion on plant sterols and their oxides in enriched beverages. Food Res. Int. 
52, 1–7, https://doi.org/10.1016/j.foodres.2013.02.024 (2013).
Acknowledgements
This project is based on research that was supported by the Hatch Multistate Research capacity funding program 
(Accession Number 1011129) from the United States Department of Agriculture National Institute of Food and 
Agriculture (USDA NIFA), and Nebraska Corn Board. The authors also thank Dr. Regis Moreau for the valuable 
discussions. The research was performed in part in the Nebraska Nanoscale Facility: National Nanotechnology 
Coordinated Infrastructure and the Nebraska Center for Materials and Nanoscience (and/or NERCF), which 
are supported by the National Science Foundation under Award ECCS: 1542182, and the Nebraska Research 
Initiative.
Author contributions
A.U. designed the study, conducted the experiments, collected data, interpreted the results and drafted the 
manuscript. O.N.C. designed the study, contributed to interpreting the results, and drafted the manuscript. All 
authors have given approval to the final version of the manuscript.
competing interests
The authors declare no competing interests.
Additional information
Correspondence and requests for materials should be addressed to O.N.C.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
